Your browser doesn't support javascript.
Unboxing herpes zoster ophthalmicus and the recombinant shingles vaccine
Medicine Today ; 22(11):33-39, 2021.
Article in English | Scopus | ID: covidwho-2011995
ABSTRACT
Reactivation of the varicella zoster virus as herpes zoster (shingles) typically affects the peripheral nerves, resulting in a painful rash, most often on the torso. However, it can also manifest ophthalmologically, affecting the ophthalmic division of the trigeminal nerve. This manifestation is associated with a particularly high level of morbidity and may result in blindness. A new recombinant shingles herpes zoster vaccine protects patients against this virus and post-infection sequelae, improving medical and psychosocial outcomes. © 2021 Medicine Today Pty Ltd. All rights reserved.
Keywords
Search on Google
Collection: Databases of international organizations Database: Scopus Topics: Vaccines Language: English Journal: Medicine Today Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: Scopus Topics: Vaccines Language: English Journal: Medicine Today Year: 2021 Document Type: Article